// App-Quantinova.ai

: TICAGRELOR DOES NOT MEDIATE ITS EARLY BENEFICIAL EFFECTS IN ST-ELEVATION MYOCARDIAL INFARCTION BY IMPROVING CORONARY MICROVASCULAR DYSFUNCTION – THE TIMES DOUBLE-BLIND RANDOMISED CONTROLLED TRIAL

Researchers

Presenter

  • Stephen P. Hoole

Principal Investigators

  • Muhammad Aetesam-ur-Rahman

  • Yi-Da Chiu

  • Tian Zhao

  • Kitty Paques

  • Joana Oliveira

  • Jo Steele

  • Melissa Duckworth

  • Sarah Fielding

  • Nick E. West

Medical Centers

  • Papworth Hospital, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Microvascular dysfunction

Biomarkers

  • Creatinine

Drug/Treatment

  • Clopidogrel bisulfate

  • Ticagrelor

  • Adenosine

  • Adenosine Intravenous

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Adaptive

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved